Severe Refractory Hypocalcemia After Administering Zoledronic Acid for Osteoporotic Fracture in Primary Hyperparathyroidism That Is Complicated Into Hungry Bone Syndrome: A Case Report

Zoledronic acid is a very effective (IV) amino bisphosphonate which is indicated in osteoporosis, hypercalcemia of malignancy, multiple myeloma, Paget’s disease, and bone metastases from solid tumors. Bisphosphonate inhibits bone resorption through actions on osteoclast activity resulting in increas...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Endocr Soc
Hlavní autoři: Alhamdan, Ali Saleh, Douba, Najah Younes, Aljamaan, Abdulaziz, Alghamdi, Abdulrahman Aidh, Alhammad, Zahrah Abbas, Alanazi, Khalid
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2021
Témata:
Bone and Mineral Metabolism
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8089785/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.450
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky